Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.33B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$985M |
| 3 |
Eli Lilly
LLY
|
+$901M |
| 4 |
Toronto Dominion Bank
TD
|
+$796M |
| 5 |
Blackrock
BLK
|
+$544M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$857M |
| 2 |
NVIDIA
NVDA
|
+$803M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$676M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$671M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.21% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.12% |
| 4 | Healthcare | 6.97% |
| 5 | Consumer Discretionary | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6001
Stoneridge
SRI
$203M
| $12K | ﹤0.01% |
2,622
-2,036
| -44% | -$10.4K |
|
|
USAS
6002
Americas Gold and Silver
USAS
$1.75B
| $12K | ﹤0.01% |
9,037
+3,767
| +71% | +$4.79K |
|
6003
WisdomTree Bloomberg US Dollar Bullish Fund
USDU
$456M
| $12K | ﹤0.01% |
416
-1,180
| -74% | -$32.4K |
|
6004
VTEX
VTEX
$620M
| $12K | ﹤0.01% |
2,397
-6,252
| -72% | -$35.5K |
|
6005
Zevra Therapeutics
ZVRA
$661M
| $12K | ﹤0.01% |
1,635
-3,269
| -67% | -$26K |
|
|
ACLX
6006
DELISTED
Arcellx
ACLX
| $11K | ﹤0.01% |
157
-726
| -82% | -$49.2K |
|
|
ADVM
6007
DELISTED
Adverum Biotechnologies
ADVM
| $11K | ﹤0.01% |
2,553
-1,003
| -28% | -$4.52K |
|
6008
Anterix
ATEX
$1.76B
| $11K | ﹤0.01% |
313
-421
| -57% | -$14.5K |
|
|
BHR
6009
Braemar Hotels & Resorts
BHR
$139M
| $11K | ﹤0.01% |
4,230
-4,073
| -49% | -$11.1K |
|
6010
BioVie
BIVI
$10.4M
| $11K | ﹤0.01% |
1,128
+278
| +33% | +$4.44K |
|
6011
Global X Blockchain ETF
BKCH
$200M
| $11K | ﹤0.01% |
342
+205
| +150% | +$9.89K |
|
6012
Cadiz
CDZI
$289M
| $11K | ﹤0.01% |
3,990
-2,007
| -33% | -$8.82K |
|
6013
Caesarstone
CSTE
$110M
| $11K | ﹤0.01% |
4,955
-707
| -12% | -$2.65K |
|
6014
Design Therapeutics
DSGN
$900M
| $11K | ﹤0.01% |
2,806
-1,261
| -31% | -$6.02K |
|
6015
State Street SPDR S&P 500 ESG ETF
EFIV
$1.04B
| $11K | ﹤0.01% |
221
-570
| -72% | -$32K |
|
|
HART
6016
DELISTED
IQ Healthy Hearts ETF
HART
| $11K | ﹤0.01% |
350
| – | – |
|
6017
John Hancock Fundamental All Cap Core ETF
JHAC
$3.79M
| $11K | ﹤0.01% |
826
-7,573
| -90% | -$109K |
|
|
JMIA
6018
Jumia Technologies
JMIA
$751M
| $11K | ﹤0.01% |
4,960
+2,720
| +121% | +$8.82K |
|
6019
Lyell Immunopharma
LYEL
$340M
| $11K | ﹤0.01% |
987
-190
| -16% | -$2.33K |
|
6020
FlexShares Disciplined Duration MBS Index Fund
MBSD
$89.1M
| $11K | ﹤0.01% |
528
| – | – |
|
|
TEAD
6021
Teads Holding Co
TEAD
$65.6M
| $11K | ﹤0.01% |
3,111
-3,899
| -56% | -$22K |
|
|
ONTF
6022
DELISTED
ON24
ONTF
| $11K | ﹤0.01% |
2,330
-1,225
| -34% | -$7.6K |
|
6023
Oportun Financial
OPRT
$355M
| $11K | ﹤0.01% |
1,916
+1,729
| +925% | +$9.51K |
|
6024
Invesco S&P SmallCap Materials ETF
PSCM
$21.4M
| $11K | ﹤0.01% |
164
| – | – |
|
6025
Sigma Lithium
SGML
$1.3B
| $11K | ﹤0.01% |
1,162
-308
| -21% | -$3.54K |
|
Similar funds
Royal Bank of Canada's Q1 2025 Portfolio in Review
As of Q1 2025, Royal Bank of Canada held 7,428 positions worth $479B, down 4.4% from $501B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q1 2025 filing shows 373 new, 3,020 increased, 3,038 reduced and 434 closed positions. Its largest new stake was Sandisk: 233,868 shares worth $11.1M. The largest sale was HCA Healthcare, an estimated $857M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q1 2025 buy was Sandisk: 233,868 shares worth $11.1M.
- Royal Bank of Canada added most to Canadian Natural Resources in Q1 2025, an estimated $1.33B increase.
- Royal Bank of Canada's biggest Q1 2025 reduction was HCA Healthcare, cutting an estimated $857M.
- Royal Bank of Canada fully exited Aspen Technology Inc in Q1 2025, selling an estimated $42.5M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $479B portfolio in Q1 2025.
- Royal Bank of Canada opened 373 new positions and closed 434 in Q1 2025.
- Royal Bank of Canada's portfolio value fell 4.4% quarter-over-quarter to $479B.
Based on Royal Bank of Canada's 13F filing for Q1 2025, filed 15 May 2025.